Xeno Transplants Financials
| XENO Stock | USD 0.0001 0.00 0.00% |
Investors should never underestimate Xeno Transplants' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Xeno Transplants' cash flow, debt, and profitability to make informed and accurate decisions about investing in Xeno Transplants.
Net Income |
|
Xeno | Select Account or Indicator |
Understanding current and past Xeno Transplants Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Xeno Transplants' financial statements are interrelated, with each one affecting the others. For example, an increase in Xeno Transplants' assets may result in an increase in income on the income statement.
Xeno Transplants Stock Summary
Xeno Transplants competes with Ventyx Biosciences, Keros Therapeutics, Crinetics Pharmaceuticals, and Vaxcyte. Xeno Transplants Corporation operates as a bio-technology research and development company. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts. XENO TRANSPLANTS is traded on PNK Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | OTCCE Exchange |
| Business Address | 143 Gardner Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Phone | 617 566 5228 |
| Currency | USD - US Dollar |
Xeno Transplants Key Financial Ratios
| Net Income | (256.37 K) | ||||
| Total Asset | 641.41 K | ||||
| Retained Earnings | (46.35 K) |
Xeno Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xeno Transplants's current stock value. Our valuation model uses many indicators to compare Xeno Transplants value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xeno Transplants competition to find correlations between indicators driving Xeno Transplants's intrinsic value. More Info.Xeno Transplants is rated fifth in current valuation category among its peers. It is rated first in price to earning category among its peers . The ratio of Current Valuation to Price To Earning for Xeno Transplants is about 121,091 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xeno Transplants' earnings, one of the primary drivers of an investment's value.Xeno Transplants Systematic Risk
Xeno Transplants' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Xeno Transplants volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Xeno Transplants correlated with the market. If Beta is less than 0 Xeno Transplants generally moves in the opposite direction as compared to the market. If Xeno Transplants Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Xeno Transplants is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Xeno Transplants is generally in the same direction as the market. If Beta > 1 Xeno Transplants moves generally in the same direction as, but more than the movement of the benchmark.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xeno Transplants. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Xeno Stock, please use our How to Invest in Xeno Transplants guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xeno Transplants. If investors know Xeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xeno Transplants listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xeno Transplants is measured differently than its book value, which is the value of Xeno that is recorded on the company's balance sheet. Investors also form their own opinion of Xeno Transplants' value that differs from its market value or its book value, called intrinsic value, which is Xeno Transplants' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xeno Transplants' market value can be influenced by many factors that don't directly affect Xeno Transplants' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xeno Transplants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xeno Transplants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xeno Transplants' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.